Development and Optimization of 7,8-Dihydroxyflavone-Loaded Polylysine/Lecithin Nanoparticles for Potential Intranasal Delivery
Pharmaceutics · 23.06.2026 · 18 (7) · 766
DOI: 10.3390/pharmaceutics18070766 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 23.06.2026. Verfasst von Sonya Salamone und 7 weiteren Autor:innen. Beteiligte Einrichtung: PhD Program in Neuroscience, Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95125 Catania, Italy. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heal Italia, Health Extended Alliance for Innovative Therapies,PNRR-NextGenerationEU.
Abstract (Originalsprache)
Background
Effective strategies for delivering neuroprotective agents to the brain remain a major challenge due to the poor solubility, rapid metabolism, and low bioavailability of promising molecules, such as 7,8-dihydroxyflavone (7,8-DHF). This small-molecule TrkB receptor agonist exhibits significant antioxidant, neuroprotective properties, and additional effects on metabolic regulation, but its therapeutic potential is limited by unfavorable pharmacokinetic characteristics. Nanotechnology-based delivery systems are increasingly explored to improve drug stability, enhance bioavailability, and facilitate direct nose-to-brain transport following intranasal administration. In this study, lipid nanoparticles encapsulating 7,8-DHF were developed using a fish-oil-based lipid core enriched with ω-3 polyunsaturated fatty acids (DHA and EPA) and naturally derived excipients, including soybean lecithin and ε-polylysine.
Methods
The formulation was optimized using a Design of Experiments (DoE) approach based on a 23 full factorial design, evaluating drug concentration, lecithin concentration, and surfactant type (Pluronic® F127 or Tween® 80). The main formulation responses considered were particle size, polydispersity index (PDI), zeta potential, and encapsulation efficiency.
Results
The optimized nanoparticles exhibited nanometric dimensions (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- PhD Program in Neuroscience, Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95125 Catania, Italy.
- Department of Drug and Health Sciences, University of Catania, 95125 Catania, Italy.
- NANOMED-Research Centre on Nanomedicine and Pharmaceutical Nanotechnology, University of Catania, 95123 Catania, Italy.
- Institute for Biomedical Research and Innovation, National Research Council, 95126 Catania, Italy.
- NanotechLab, Traditional and Innovative Pharmaceutical Technologies Center, (Te.Far.T.I.), Department Life Sciences, University of Modena and Reggio Emilia, Via Campi 103, 41125 Modena, Italy.
ORCID-Profile: Rosalia Pellitteri, Ilaria Ottonelli, Elide Zingale, Cinzia Cimino, Barbara Ruozi, Teresa Musumeci, Rosario Pignatello
Förderung
- Heal Italia, Health Extended Alliance for Innovative Therapies,PNRR-NextGenerationEU
Zitieren
APA
Salamone, S., Pellitteri, R., Ottonelli, I., Zingale, E., Cimino, C., Ruozi, B., Musumeci, T., & Pignatello, R. (2026). Development and Optimization of 7,8-Dihydroxyflavone-Loaded Polylysine/Lecithin Nanoparticles for Potential Intranasal Delivery. Pharmaceutics, 18(7), 766. https://doi.org/10.3390/pharmaceutics18070766
Vancouver
Salamone S, Pellitteri R, Ottonelli I, Zingale E, Cimino C, Ruozi B, et al. Development and Optimization of 7,8-Dihydroxyflavone-Loaded Polylysine/Lecithin Nanoparticles for Potential Intranasal Delivery. Pharmaceutics. 2026;18(7):766. doi:10.3390/pharmaceutics18070766
BibTeX
@article{Salamone2026,
author = {Salamone, Sonya and Pellitteri, Rosalia and Ottonelli, Ilaria and Zingale, Elide and Cimino, Cinzia and Ruozi, Barbara and Musumeci, Teresa and Pignatello, Rosario},
title = {Development and Optimization of 7,8-Dihydroxyflavone-Loaded Polylysine/Lecithin Nanoparticles for Potential Intranasal Delivery},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {7},
pages = {766},
doi = {10.3390/pharmaceutics18070766}
}
EUVIMED